Description: Leverage the natural abilities of the human trophoblast stem cell to achieve the full potential of regenerative medicine. Originating from the earliest ethical source, the discovery of human trophoblast stem cell (hTSC) is a quantum leap in stem cell research.
We are the first company to commercialize human Trophoblastic Stem Cells (TSC) from embryonic-stage pre-placental tissue. By working with us, you build off our position as first-to-market proprietary cell source.
Accelerated Biosciences lets you put capital to work in the right places by leveraging our expertise and efficiency in producing TSCs.
Our TSCs come from ectopic pregnancies 4-8 weeks post-fertilization. Earlier sourced cells are naive, powerful, and lively. They have a high plasticity making them an ideal source for therapy development.